Skip to main content
Clinical Trials/NCT03387930
NCT03387930
Unknown
Not Applicable

The Role of Lumbar Multifidus Characteristics in the Development of Low Back Pain

The Hong Kong Polytechnic University1 site in 1 country140 target enrollmentAugust 1, 2017
ConditionsLow Back Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
The Hong Kong Polytechnic University
Enrollment
140
Locations
1
Primary Endpoint
11-point numeric pain rating scale (NPRS) for low back pain
Last Updated
5 years ago

Overview

Brief Summary

Low back pain (LBP) is a severe epidemic in the world. Despite its high prevalence, 90% of the cases have no identifiable cause. Approximately 44% of them experience recurrent LBP within one year and 10% of them develop chronic LBP that lasts for three months or more.

Mechanically, the lumbar spine is unstable and requires spinal muscle to maintain spinal stability and to prevent injuries. Lumbar multifidus (LM) muscle is thought to be the major spinal stabilizer responsible for spinal stability and spinal proprioception. Prior studies have revealed that increased fat infiltration, atrophy or activation deficits of LM in patients with LBP as compared to asymptomatic individuals. Unfortunately, inconsistent findings have also been reported.

Although prior research attempted to determine if abnormal LM characteristics can inform clinical decision-making, their results are limited because they only investigated a single LM characteristic at a time, which might not reflect the actual LM condition. Further, many studies adopted cross-sectional design that could not reveal the casual relations between abnormal LM characteristics and LBP. As such, the current study aims to identify specific LM characteristics that can predict new episode of LBP in asymptomatic individuals, and recurrent/chronic LBP in individuals with LBP at baseline.

Detailed Description

Low back pain (LBP) is a severe epidemic in the world. Despite its high prevalence, 90% of the cases have no identifiable cause. While most people with LBP recover shortly after onset, approximately 44% of them experience recurrent LBP within one year and 10% of them develop chronic LBP that lasts for three months or more. Mechanically, the lumbar spine is unstable and requires spinal muscle to maintain spinal stability and to prevent injuries. Lumbar multifidus (LM) muscle is thought to be the major spinal stabilizer responsible for spinal stability and spinal proprioception. Different cross-sectional studies have revealed that increased fat infiltration, atrophy or activation deficits of LM in patients with LBP as compared to asymptomatic individuals. Research has shown that abnormal morphology or activation of LM is associated with LBP intensity/location, or LBP-related disability. Unfortunately, inconsistent findings have also been reported. Although prior research attempted to determine if abnormal LM characteristics can inform clinical decision-making, their results are limited because they only investigated a single LM characteristic at a time, which might not reflect the actual LM condition. Further, many studies adopted cross-sectional design that could not reveal the casual relations between abnormal LM characteristics and LBP. Given the above, the current study aims to identify specific LM characteristics that can predict new episode of LBP in asymptomatic individuals, and recurrent/chronic LBP in individuals with LBP at baseline.

Registry
clinicaltrials.gov
Start Date
August 1, 2017
End Date
June 30, 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Arnold Wong Yu Lok

Assistant Professor

The Hong Kong Polytechnic University

Eligibility Criteria

Inclusion Criteria

  • aged 18 to 65 years
  • Symptomatic participants should have LBP that requires medical consultation(s) in the last three months
  • LBP intensity of at least 5 on the 11-point numeric pain rating scale at baseline (for symptomatic participants)
  • Asymptomatic participants should be pain free at baseline, and should not have LBP in the last year nor LBP lasting more than a week in the last 3 years

Exclusion Criteria

  • a history of neurological disease or vestibular impairment
  • systemic inflammatory disease
  • prior spinal surgery
  • acute/chronic neuropathy or radiculopathy
  • spinal infections/fractures/tumors, metabolic disorders,
  • medical 'red flags'

Outcomes

Primary Outcomes

11-point numeric pain rating scale (NPRS) for low back pain

Time Frame: 2 years

The current pain intensity of each participant will be quantified by an 11-point NPRS, where 0 means no pain and 10 means the worst imaginable pain.

Secondary Outcomes

  • Morphometry of lumbar multifidus(2 years)
  • Proprioception of lumbar multifidus(2 years)
  • Stiffness of lumbar multifidus(2 years)
  • Fatty infiltration of lumbar multifidus(2 years)

Study Sites (1)

Loading locations...

Similar Trials